TY - JOUR
T1 - Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification
T2 - The ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology
AU - Nadarajah, Ramesh
AU - Ludman, Peter
AU - Laroche, Cecile
AU - Appelman, Yolande
AU - Brugaletta, Salvatore
AU - Budaj, Andrzej
AU - Bueno, Hector
AU - Huber, Kurt
AU - Kunadian, Vijay
AU - Leonardi, Sergio
AU - Lettino, Maddalena
AU - on behalf of the NSTEMI investigator group
AU - Milasinovic, Dejan
AU - Gale, Chris P.
N1 - Funding Information: C.P.G. reports personal fees from AstraZeneca, Amgen, Bayer, Boehrinher-Ingelheim, Daiichi Sankyo, Vifor, Pharma, Menarini, Wondr Medical, Raisio Group, and Oxford University Press. He has received educational and research grants from BMS, Abbott inc., the British Heart Foundation, National Institute of Health Research, Horizon 2020, and from the European Society of Cardiology, outside the submitted work. Funding Information: Y.A. reports a research grant from the Dutch Heart Foundation. Publisher Copyright: © 2023 Oxford University Press. All rights reserved.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Background The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification. Methods and Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by World Bank results country income classification. Quality of care was evaluated based on 12 guideline-recommended care interventions. The all-or-none scoring composite performance measure was used to define receipt of optimal care. Outcomes included in-hospital acute heart failure, stroke/transient ischaemic attack, and death, and 30-day mortality. Patients admitted with NSTEMI in low to lower-middle-income countries (LLMICs), compared with patients in HICs, were younger, more commonly diabetic, and current smokers, but with a lower burden of other comorbidities, and 76.7% met very high risk criteria for an immediate invasive strategy. Invasive coronary angiography use increased with ascending income classification (LLMICs, 79.2%; upper middle income countries [UMICs], 83.7%; HICs, 91.0%), but overall care quality did not (>80% of eligible interventions achieved: LLMICS, 64.8%; UMICs 69.6%; HICs 55.1%). Rates of acute heart failure (LLMICS, 21.3%; UMICs, 12.1%; HICs, 6.8%; P < 0.001), stroke/transient ischaemic attack (LLMICS: 2.5%; UMICs: 1.5%; HICs: 0.9%; P = 0.04), in-hospital mortality (LLMICS, 3.6%; UMICs: 2.8%; HICs: 1.0%; P < 0.001) and 30-day mortality (LLMICs, 4.9%; UMICs, 3.9%; HICs, 1.5%; P < 0.001) exhibited an inverse economic gradient. Conclusion Patients with NSTEMI in LLMICs present with fewer comorbidities but a more advanced stage of acute disease, and have worse outcomes compared with HICs. A cardiovascular health narrative is needed to address this inequity across economic boundaries.
AB - Background The majority of NSTEMI burden resides outside high-income countries (HICs). We describe presentation, care, and outcomes of NSTEMI by country income classification. Methods and Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by World Bank results country income classification. Quality of care was evaluated based on 12 guideline-recommended care interventions. The all-or-none scoring composite performance measure was used to define receipt of optimal care. Outcomes included in-hospital acute heart failure, stroke/transient ischaemic attack, and death, and 30-day mortality. Patients admitted with NSTEMI in low to lower-middle-income countries (LLMICs), compared with patients in HICs, were younger, more commonly diabetic, and current smokers, but with a lower burden of other comorbidities, and 76.7% met very high risk criteria for an immediate invasive strategy. Invasive coronary angiography use increased with ascending income classification (LLMICs, 79.2%; upper middle income countries [UMICs], 83.7%; HICs, 91.0%), but overall care quality did not (>80% of eligible interventions achieved: LLMICS, 64.8%; UMICs 69.6%; HICs 55.1%). Rates of acute heart failure (LLMICS, 21.3%; UMICs, 12.1%; HICs, 6.8%; P < 0.001), stroke/transient ischaemic attack (LLMICS: 2.5%; UMICs: 1.5%; HICs: 0.9%; P = 0.04), in-hospital mortality (LLMICS, 3.6%; UMICs: 2.8%; HICs: 1.0%; P < 0.001) and 30-day mortality (LLMICs, 4.9%; UMICs, 3.9%; HICs, 1.5%; P < 0.001) exhibited an inverse economic gradient. Conclusion Patients with NSTEMI in LLMICs present with fewer comorbidities but a more advanced stage of acute disease, and have worse outcomes compared with HICs. A cardiovascular health narrative is needed to address this inequity across economic boundaries.
KW - Country income
KW - Mortality
KW - NSTEMI
KW - Quality indicators
KW - Registry
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85175460351&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36737420
U2 - https://doi.org/10.1093/ehjqcco/qcad008
DO - https://doi.org/10.1093/ehjqcco/qcad008
M3 - Article
C2 - 36737420
SN - 2058-5225
VL - 9
SP - 552
EP - 563
JO - European Heart Journal - Quality of Care and Clinical Outcomes
JF - European Heart Journal - Quality of Care and Clinical Outcomes
IS - 6
ER -